SUTRO BIOPHARMA INC's ticker is STRO and the CUSIP is 869367102. A total of 81 filers reported holding SUTRO BIOPHARMA INC in Q2 2020. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $1,152,000 | -70.1% | 148,400 | -56.2% | 0.34% | -63.9% |
| Q2 2019 | $3,858,000 | -15.1% | 339,059 | -15.0% | 0.93% | -24.1% |
| Q1 2019 | $4,542,000 | +78.6% | 398,796 | +41.5% | 1.23% | +32.4% |
| Q4 2018 | $2,543,000 | -27.1% | 281,914 | +21.2% | 0.93% | -22.6% |
| Q3 2018 | $3,488,000 | – | 232,539 | – | 1.20% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SV Health Investors, LLC | 1,824,542 | $39,611,000 | 19.08% |
| Samsara BioCapital, LLC | 1,675,579 | $36,377,000 | 3.66% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 185,000 | $4,016,000 | 2.33% |
| Affinity Asset Advisors, LLC | 200,000 | $4,342,000 | 2.30% |
| Altium Capital Management LP | 276,719 | $6,008,000 | 2.24% |
| FRAZIER MANAGEMENT LLC | 1,001,421 | $21,741,000 | 1.67% |
| BVF INC/IL | 1,854,162 | $40,254,000 | 1.58% |
| Asymmetry Capital Management, L.P. | 157,583 | $3,421,000 | 1.56% |
| Parkman Healthcare Partners LLC | 266,645 | $5,789,000 | 1.48% |
| AJU IB Investment Co., Ltd. | 175,000 | $3,799,000 | 1.44% |